CN1238021C - Medicine for treating osteoproliferation - Google Patents

Medicine for treating osteoproliferation Download PDF

Info

Publication number
CN1238021C
CN1238021C CNB031562655A CN03156265A CN1238021C CN 1238021 C CN1238021 C CN 1238021C CN B031562655 A CNB031562655 A CN B031562655A CN 03156265 A CN03156265 A CN 03156265A CN 1238021 C CN1238021 C CN 1238021C
Authority
CN
China
Prior art keywords
radix
root
medicine
hyperosteogeny
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB031562655A
Other languages
Chinese (zh)
Other versions
CN1490044A (en
Inventor
杨林颜
杨校一
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB031562655A priority Critical patent/CN1238021C/en
Publication of CN1490044A publication Critical patent/CN1490044A/en
Application granted granted Critical
Publication of CN1238021C publication Critical patent/CN1238021C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The present invention relates to a medicine for treating osteoproliferation, which comprises the following components as raw materials: ginseng, stir-fried ovate atractylodes root, Chinaroot greenbrier rhizome, licorice root, dried rehmannia root, angelica, hemlock parsley, red peony root, astragalus root, cassia twig, platycodon root, twotooth achyranthes root, hairy deer-horn(hairy antler), placenta, sea horse, eucommia bark, wool dog, himalayan teasel root, epimedium saggitatum, danshen root, earthworm, suberect spatholobus stem, scorpio, sanguis draconis, saffron, eupolyphaga, catechu, fortune's drynaria rhizome, Chinese caterpillar fungus, matrimony vine, tortoise glue, walnut kernel, frankincense, myrrh, medicated leaven, hawthorn fruit and malt. The components are prepared into various kinds of formulations by crushing, mixing and sieving. The present invention has the advantages of conspicuous curative effect and no toxic side effect.

Description

A kind of medicine for the treatment of hyperosteogeny
Technical field
The present invention relates to a kind of medicine for the treatment of hyperosteogeny, relating in particular to a kind of is the medicine of feedstock production with the multi-flavor natural Chinese medicine.
Background technology
Hyperosteogeny is a big difficult disease of present world orthopaedics, its serious harm, wrecks human health, gently then makes people's disability and self care ability, and is heavy then the people is paralysed and be ill lifelong.Early have the doctor to say: the saying of ten people, nine hemorrhoid, can reach ten people now has nine people to suffer from hyperosteogeny, the serious harm people's health.The common cause of disease of hyperosteogeny has following several: serious congenital renal function goes down; Excessive physical work; Because of the long-term a large amount of hormone medicines that use of certain disease; Long-term excessive drinking, humidity; Edible chemical fertilizer, pesticide short long grain and vegetable are impelled osteoporosis, calcium deficiency, bone marrow inanition.
The hyperosteogeny main clinical manifestation is: 1, hyperosteogeny: waist is stiff, limitation of activity, can only bend body during walking and the capable lower limb that reflex to, sacraligia is one-sided or toss about and can radiate to lower limb, pain emitted to groin when last waist was impaired, outside vertebra spinous process is other before the thigh tenderness, make waist after exhibition limited, tibialis anterior, toe extensor ability weaken; The compressing lower limb nerve influenced blood circulation when hypertrophy was serious, was directed at the lower limb muscles fistula and contracted, and cold is sent out at the end slightly.2, hyperosteogeny: can be divided into 4 kinds of types card: 1) through the root type: have cervicodynia and cervical region to send out deadlock earlier, shoulder pain and upper limb radiating pain are arranged then, the upper limb grip goes down, and arm finger persistence is ached, distending pain, amyotrophy.2) marrow type: hand is numb and movable ineffective, or walking is unstable, can not easily fall at a quick pace, can not leaping over obstacles, and poor, the numb limbs and tense tendons of the power of holding, gatism, high-order hemiplegia.3) vertebral artery type: dizzy, dizzy, even damping off, to feel sick sometimes, vomiting, blurring of vision, tinnitus, deafness, this kind more to be seen.4) sympathetic type: migraine, pillow back pain, blurring of vision, photophobia, shed tears, tinnitus, dysaudia.3, prolapse of lumbar intervertebral disc hypertrophy type: prolapse of lumbar intervertebral disc, most in the waist twisting or suffer from cold, or the cold-damp sequela.Main cause is because outthrust stimulates compressing fibrous ring top layer, due to posterior longitudinal ligament and the dura mater bundle.Bone marrow nuclear is deviate from from the fibrous ring of fracture.When this outthrust greatly or root is excited nerve in compressing outside the deflection back, lumbago then appears, pain starts from buttocks and is radiated to the shank outside downwards along the thigh rear side, instep and the outside, vola or heel, when station power, walking, cough, sneeze or firmly during defecation pain increase the weight of.As untimely diagnosis and treatment, blood is obstructed, easily forms periosteal proliferation, pressuring nerve, and the lower limb muscles fistula contracts.
Clinical and Pathological Analysis thinks no matter hyperosteogeny by which kind of reason is caused, all is to cause osteoarthrosis, hyaloidin hypertrophy, produces bony spur, oppresses blood vessel, nerve, causes blood obstructed.Say by theory of Chinese medical science: the kidney generating marrow and dominating bone, have one's ideas straightened out in ear and two the moon, sensible in brain, its Hua Zaifa.Be the source of reproductive development, physiological function, main store essential substances, people's congenital essence is hidden in kidney, but the continuous nourishing of acquired essence must be arranged, its effect of competence exertion.So the kidney essense abundance, kidney qi is just vigorous.Deficiency of kidney-essence, kidney qi also goes down thereupon.
The radical cure hyperosteogeny is this with the kidney invigorating, the vital essence foot of kidney, and an aspect of promotion growth promoter, because of kidney storing essence, the smart marrow of giving birth to, marrow occupy in the bone, nourishes skeleton.Therefore, the kidney essense abundance, then marrow is biochemical active, and skeleton obtains the abundant nourishing of marrow and firm strong.Make Conception Vessel and Governor Vessel essence and blood abundance, just can produce liquid in the bone marrow and supply each osteoarticular fortune and trackslip movingly, do not produce the friction between bone and the bone.
At present, the medicine of treatment hyperosteogeny exists cure rate not high, easily the shortcoming of recurrence.
Summary of the invention
The purpose of this invention is to provide a kind of medicine for the treatment of hyperosteogeny, especially providing a kind of is the medicine of feedstock production with the multi-flavor natural Chinese medicine, has overcome the shortcoming of the medicine of above-mentioned treatment hyperosteogeny.
The objective of the invention is to be achieved through the following technical solutions:
A kind of medicine for the treatment of hyperosteogeny is by the medicament that comprises that following component raw material is made: Radix Ginseng, Rhizoma Atractylodis Macrocephalae, Poria, Radix Glycyrrhizae, Radix Rehmanniae Preparata, Radix Angelicae Sinensis, Rhizoma Chuanxiong, Radix Paeoniae Rubra, Radix Astragali, Ramulus Cinnamomi, Radix Platycodonis, Radix Achyranthis Bidentatae, Cornu Cervi Pantotrichum, Placenta Hominis, Hippocampus, the Cortex Eucommiae, hair Canis familiaris L., Radix Dipsaci, Herba Epimedii, Radix Salviae Miltiorrhizae, Pheretima, Caulis Spatholobi, Scorpio, Sanguis Draxonis, Stigma Croci, eupolyphage sece steleophaga, catechu, drynaria baronii, Cordyceps, Fructus Lycii, Colla Plastri Testudinis, Semen Juglandis, Olibanum, Myrrha, Massa Medicata Fermentata, Fructus Crataegi, Fructus Hordei Germinatus;
Described medicine is by the medicament that comprises that following parts by weight of component raw material is made: Radix Ginseng 20-60, Rhizoma Atractylodis Macrocephalae 20-40, Poria 10-30, Radix Glycyrrhizae 10-30, Radix Rehmanniae Preparata 30-70, Radix Angelicae Sinensis 20-60, Rhizoma Chuanxiong 20-40, Radix Paeoniae Rubra 10-30, Radix Astragali 30-70, Ramulus Cinnamomi 10-20, Radix Platycodonis 20-40, Radix Achyranthis Bidentatae 10-30, Cornu Cervi Pantotrichum 20-40, Placenta Hominis 20-60, Hippocampus 20-60, Cortex Eucommiae 20-40, hair Canis familiaris L. 20-40, Radix Dipsaci 20-40, Herba Epimedii 20-40, Radix Salviae Miltiorrhizae 20-60, Pheretima 20-40, Caulis Spatholobi 20-60, Scorpio 20-40, Sanguis Draxonis 10-30, Stigma Croci 10-30, eupolyphage sece steleophaga 10-30, catechu 10-30, drynaria baronii 20-60, Cordyceps 20-60, Fructus Lycii 20-60, Colla Plastri Testudinis 20-60, Semen Juglandis 30-70, Olibanum 20-40, Myrrha 20-40, Massa Medicata Fermentata 10-30, Fructus Crataegi 10-30, Fructus Hordei Germinatus 10-30;
Described medicine is preferably the medicament that following parts by weight of component raw material is made: Radix Ginseng 40, Rhizoma Atractylodis Macrocephalae 30, Poria 20, Radix Glycyrrhizae 20, Radix Rehmanniae Preparata 50, Radix Angelicae Sinensis 40, Rhizoma Chuanxiong 30, Radix Paeoniae Rubra 20, Radix Astragali 50, Ramulus Cinnamomi 20, Radix Platycodonis 30, Radix Achyranthis Bidentatae 20, Cornu Cervi Pantotrichum 30, Placenta Hominis 40, Hippocampus 40, the Cortex Eucommiae 30, hair Canis familiaris L. 30, Radix Dipsaci 30, Herba Epimedii 30, Radix Salviae Miltiorrhizae 40, Pheretima 30, Caulis Spatholobi 40, Scorpio 30, Sanguis Draxonis 20, Stigma Croci 20, eupolyphage sece steleophaga 20, catechu 20, drynaria baronii 40, Cordyceps 40, Fructus Lycii 40, Colla Plastri Testudinis 40, Semen Juglandis 50, Olibanum 30, Myrrha 30, Massa Medicata Fermentata 20, Fructus Crataegi 20, Fructus Hordei Germinatus 20;
Described medicament can be the above medicament of any pharmaceutics, especially is powder, tablet, capsule, granule, oral liquid etc.
The present invention treats the preparation method of hyperosteogeny medicine, may further comprise the steps: get above-mentioned raw materials, grind respectively, sieve, with above-mentioned sieving mix homogeneously, make medicament more according to a conventional method;
Described sieving is the 10-400 mesh sieve, especially is 200 mesh sieves.
Solution of the present invention is based on motherland's medical science to treating the understanding and the Therapeutic Principle of various hyperosteogeny diseases and regulating body function mechanism, achieve with reference to modern pharmacological research, from motherland's medicine treasure-house, the crude drug of the hyperosteogeny that the treatment that filters out is all types of by the monarch prescription of theory of Chinese medical science, is selected the essence, meet benefiting qi and nourishing blood, the tonifying kidney-yin invigorating kidney-YANG, warm promoting blood circulation, the rule of treatment rule of treatment of blood circulation promoting and blood stasis dispelling.
Medicine pharmacology analysis of the present invention is as follows: four monarch's Radix Ginsengs, Rhizoma Atractylodis Macrocephalae, Poria, Radix Glycyrrhizae QI invigorating, and four thing Radix Rehmanniaes Preparata, Radix Angelicae Sinensis, Rhizoma Chuanxiong, Radix Paeoniae Rubra are enriched blood; Placenta Hominis, Radix Astragali, Semen Juglandis, Cordyceps, replenishing vital essence and invigorating vital QI nourish blood; Cornu Cervi Pantotrichum, kidney-replenishing benefiting essence-blood can the dredging DU Meridian arteries and veins and YANG invigorating; Colla Plastri Testudinis, Fructus Lycii, the tonifying kidney-yin kidney tonifying is built bone, can lead to conception vessel and nourishing YIN; Herba Epimedii, the Cortex Eucommiae, hair Canis familiaris L., Radix Dipsaci, Hippocampus, the assosting effect of kidney invigorating and YANG supporting; Sanguis Draxonis, eupolyphage sece steleophaga, Radix Salviae Miltiorrhizae, Stigma Croci, Caulis Spatholobi, catechu, drynaria baronii, Olibanum Myrrha, blood circulation promoting and blood stasis dispelling; Pheretima, Scorpio are separated through collateral dredging; Ramulus Cinnamomi plays the warming the meridian effect, can guide blood vessels into the extremity end slightly; Radix Platycodonis is can priming up, and Radix Achyranthis Bidentatae is can priming descending to play the tying-in effect; Fructus Hordei Germinatus, Fructus Crataegi, Massa Medicata Fermentata, agitate the gastric qi appetite strengthening, extract vigour.Above medicine monarch, reasonable compatibility.
Medicine of the present invention has the following advantages:
1, can treat all types of hyperosteogenies,, meet benefiting qi and nourishing blood by the theory of Chinese medical science prescription, the tonifying kidney-yin invigorating kidney-YANG, warm promoting blood circulation, the rule of treatment rule of treatment of blood circulation promoting and blood stasis dispelling, evident in efficacy.
2, with the natural drug prescription, have no side effect.
For proof medicine of the present invention described therapeutic effect, from year January in April, 1999-2002, choose cervical spondylosis, thoracic vertebra, lumbar vertebra, the 1000 routine clinical observations of hyperosteogenys such as knee joint, age 42-65 year.Stochastic sampling is divided into two groups, this medicine group 880 examples wherein, and M-F is 2: 1.Matched group placebo medicine group 120 examples.Curative effect is passed judgment on and is divided level Four: cures, produce effects is effectively, invalid.The therapeutic outcome contrast, of the present invention group obviously is better than matched group.Cure 616 examples, account for 70%, produce effects 176 examples account for 20%, and symptom after taking medicine disappears, no pain numbness sense, activity freely, the work that regains one's strength is substantially followed up a case by regular visits to 1 year nothing and is recurred.It is the shortest 10 days to take medicine, the longest 60 days, and symptom after taking medicine begins to alleviate, and be 6 days average time, is 4 days the soonest, and wherein 400 example treatment back check X sheets show that bone damage is obviously repaired and erosion stops, and effective 88 examples account for 10%.Effective percentage 100%, cure rate 90%, statistical analysis P value<0.01.
Method of administration, oral, each 6 grams, 2 times on the one, took in 3 hours after meal, 3 months is a course of treatment.
Wherein some cases is as follows:
Case 1
Zhang Zhong, 35 years old, the man, hyperosteogeny had 3 years, hematoma fleshization, and the bone edge forms the hyperosteogeny of thorn-like and lip sample, pain is often felt at the lumbar vertebra position, waist is stretched not straight, lumbago unbearably, the difficulty of standing up and stand all, stiff sensation is arranged, walk gruelling, can not be engaged in work, go to a doctor in April, 1999, after treating 40 days, and not recurrence so far.
Case 2
Zhang Yujuan, the woman, 37 years old, do the movie technology, expose to the weather for a long time, cause hyperosteogeny by wind and cold, take medicine 1 course of treatment, can work.
Case 3
Open, the man 50 years old, causes prolapse of lumbar intervertebral disc by spraining; Can not walk, lie down and to stand up; Take medicine 1 course of treatment, promptly heal entirely.
Case 4
Mao Yufen, the woman, 45 years old, suffer from hyperosteogeny 3 years, right side hand muscle meat fistula contracts and sends out coolly, can not work, and takes medicine 2 courses of treatment, and existing hands generates heat, can do general work.
Case 5
State army, man, 40 years old, suffer from lumbar and cervical vertebra hyperosteogeny, normal sense has head, neck, shoulder pain, upper limb numbness, and hands can not be carried thing, muscle weakness, dizziness, dim eyesight, tinnitus, arrhythmia, can only be on the hole recumbency, black and white day pain unbearably, go to a doctor in July, 2000, take medicine 1 course of treatment, recovery from illness can go to the other places to do manual work, so far not recurrence.
Case 6
Jiang Guifang, the woman, 53 years old, this person suffered from hyperosteogeny, and pressuring nerve causes right side hand muscle meat fistula to contract, and hands even have a meal all send less than the mouth, takes medicine 2 courses of treatment, and the state of an illness is basic complete.Now can do general work.
The specific embodiment
Embodiment 1
Granule
Take by weighing each raw material (kg) by following proportioning: Radix Ginseng 40, Rhizoma Atractylodis Macrocephalae 30, Poria 20, Radix Glycyrrhizae 20, Radix Rehmanniae Preparata 50, Radix Angelicae Sinensis 40, Rhizoma Chuanxiong 30, Radix Paeoniae Rubra 20, Radix Astragali 50, Ramulus Cinnamomi 20, Radix Platycodonis 30, Radix Achyranthis Bidentatae 20, Cornu Cervi Pantotrichum 30, Placenta Hominis 40, Hippocampus 40, the Cortex Eucommiae 30, hair Canis familiaris L. 30, Radix Dipsaci 30, Herba Epimedii 30, Radix Salviae Miltiorrhizae 40, Pheretima 30, Caulis Spatholobi 40, Scorpio 30, Sanguis Draxonis 20, Stigma Croci 20, eupolyphage sece steleophaga 20, catechu 20, drynaria baronii 40, Cordyceps 40, Fructus Lycii 40, Colla Plastri Testudinis 40, Semen Juglandis 50, Olibanum 30, Myrrha 30, Massa Medicata Fermentata 20, Fructus Crataegi 20, Fructus Hordei Germinatus 20.
Preparation method is: get above-mentioned medical material, grind, 200 orders sieve; Above-mentioned thing is mixed, add sucrose 100kg, be stirred into thickly, granulate, cross 10 orders, packing, 6 gram/bags, ultraviolet is sterilized, promptly.
Embodiment 2
Powder
Take by weighing each raw material (kg) by following proportioning: Radix Ginseng 60, Rhizoma Atractylodis Macrocephalae 40, Poria 30, Radix Glycyrrhizae 30, Radix Rehmanniae Preparata 70, Radix Angelicae Sinensis 60, Rhizoma Chuanxiong 40, Radix Paeoniae Rubra 30, Radix Astragali 70, Ramulus Cinnamomi 20, Radix Platycodonis 40, Radix Achyranthis Bidentatae 30, Cornu Cervi Pantotrichum 40, Placenta Hominis 60, Hippocampus 60, the Cortex Eucommiae 40, hair Canis familiaris L. 40, Radix Dipsaci 40, Herba Epimedii 40, Radix Salviae Miltiorrhizae 60, Pheretima 40, Caulis Spatholobi 60, Scorpio 40, Sanguis Draxonis 30, Stigma Croci 30, eupolyphage sece steleophaga 30, catechu 30, drynaria baronii 60, Cordyceps 60, Fructus Lycii 60, Colla Plastri Testudinis 60, Semen Juglandis 70, Olibanum 40, Myrrha 40, Massa Medicata Fermentata 30, Fructus Crataegi 30, Fructus Hordei Germinatus 30;
Preparation method is: get above-mentioned medical material, grind, 400 orders sieve; With above-mentioned thing mix homogeneously, make powder, packing, 6 gram/bags, the ultraviolet sterilization, promptly.
Embodiment 3
Tablet
Take by weighing each raw material (kg) by following proportioning: Radix Ginseng 20, Rhizoma Atractylodis Macrocephalae 20, Poria 10, Radix Glycyrrhizae 10, Radix Rehmanniae Preparata 30, Radix Angelicae Sinensis 20, Rhizoma Chuanxiong 20, Radix Paeoniae Rubra 10, Radix Astragali 30, Ramulus Cinnamomi 10, Radix Platycodonis 20, Radix Achyranthis Bidentatae 10, Cornu Cervi Pantotrichum 20, Placenta Hominis 20, Hippocampus 20, the Cortex Eucommiae 20, hair Canis familiaris L. 20, Radix Dipsaci 20, Herba Epimedii 20, Radix Salviae Miltiorrhizae 20, Pheretima 20, Caulis Spatholobi 20, Scorpio 20, Sanguis Draxonis 10, Stigma Croci 10, eupolyphage sece steleophaga 10, catechu 10, drynaria baronii 20, Cordyceps 20, Fructus Lycii 20, Colla Plastri Testudinis 20, Semen Juglandis 30, Olibanum 20, Myrrha 20, Massa Medicata Fermentata 10, Fructus Crataegi 10, Fructus Hordei Germinatus 10;
Preparation method is: mentioned component is decocted with water 60 minutes, and decoction liquor 200 μ m sieve filtration, and the 60% ethanol simmer down to piece that wets is granulated, 200 orders that sieve, and tabletting, logical 100 ℃ of sterilizations of steam, promptly.
Embodiment 4
Capsule
Take by weighing each raw material (kg) by following proportioning: Radix Ginseng 25, Rhizoma Atractylodis Macrocephalae 25, Poria 15, Radix Glycyrrhizae 15, Radix Rehmanniae Preparata 35, Radix Angelicae Sinensis 25, Rhizoma Chuanxiong 25, Radix Paeoniae Rubra 15, Radix Astragali 35, Ramulus Cinnamomi 15, Radix Platycodonis 25, Radix Achyranthis Bidentatae 15, Cornu Cervi Pantotrichum 25, Placenta Hominis 25, Hippocampus 25, the Cortex Eucommiae 25, hair Canis familiaris L. 25, Radix Dipsaci 25, Herba Epimedii 25, Radix Salviae Miltiorrhizae 25, Pheretima 25, Caulis Spatholobi 25, Scorpio 25, Sanguis Draxonis 15, Stigma Croci 15, eupolyphage sece steleophaga 15, catechu 15, drynaria baronii 25, Cordyceps 25, Fructus Lycii 25, Colla Plastri Testudinis 25, Semen Juglandis 35, Olibanum 25, Myrrha 25, Massa Medicata Fermentata 15, Fructus Crataegi 15, Fructus Hordei Germinatus 15.
Preparation method is:
Get Hippocampus, Scorpio, eupolyphage sece steleophaga, Pheretima, Cordyceps, Colla Plastri Testudinis, Massa Medicata Fermentata, Semen Juglandis, Placenta Hominis, Cornu Cervi Pantotrichum, grind into fine powder, cross 200 mesh sieves, standby;
Above-mentioned clout added 75% ethanol is an amount of to be extracted 45 minutes, extracts 2 times, merge decoction liquor, 200 μ m sieves filtrations, enter above-mentioned standby material, mixing, and the 60% ethanol simmer down to piece that wets, granulation, 200 orders that sieve, encapsulated, lead to 100 ℃ of sterilizations of steam, promptly.
Embodiment 5
Oral liquid
Take by weighing each raw material (kg) by following proportioning: Radix Ginseng 55, Rhizoma Atractylodis Macrocephalae 35, Poria 25, Radix Glycyrrhizae 25, Radix Rehmanniae Preparata 65, Radix Angelicae Sinensis 55, Rhizoma Chuanxiong 35, Radix Paeoniae Rubra 25, Radix Astragali 65, Ramulus Cinnamomi 15, Radix Platycodonis 35, Radix Achyranthis Bidentatae 25, Cornu Cervi Pantotrichum 35, Placenta Hominis 55, Hippocampus 55, the Cortex Eucommiae 35, hair Canis familiaris L. 35, Radix Dipsaci 35, Herba Epimedii 35, Radix Salviae Miltiorrhizae 55, Pheretima 35, Caulis Spatholobi 55, Scorpio 35, Sanguis Draxonis 25, Stigma Croci 25, eupolyphage sece steleophaga 25, catechu 25, drynaria baronii 55, Cordyceps 55, Fructus Lycii 55, Colla Plastri Testudinis 55, Semen Juglandis 65, Olibanum 35, Myrrha 35, Massa Medicata Fermentata 25, Fructus Crataegi 25, Fructus Hordei Germinatus 25.
Preparation method is:
Get above-mentioned raw materials and add an amount of extraction of water 60 minutes, extract 2 times, merge decoction liquor, 200 μ m sieve filtration, and fill 10ml/ props up, 100 ℃ of sterilizations of logical steam 30 minutes, promptly.

Claims (5)

1, a kind of medicine for the treatment of hyperosteogeny is made by the component of following weight portion: Radix Ginseng 20-60, Rhizoma Atractylodis Macrocephalae 20-40, Poria 10-30, Radix Glycyrrhizae 10-30, Radix Rehmanniae Preparata 30-70, Radix Angelicae Sinensis 20-60, Rhizoma Chuanxiong 20-40, Radix Paeoniae Rubra 10-30, Radix Astragali 30-70, Ramulus Cinnamomi 10-20, Radix Platycodonis 20-40, Radix Achyranthis Bidentatae 10-30, Cornu Cervi Pantotrichum 20-40, Placenta Hominis 20-60, Hippocampus 20-60, Cortex Eucommiae 20-40, hair Canis familiaris L. 20-40, Radix Dipsaci 20-40, Herba Epimedii 20-40, Radix Salviae Miltiorrhizae 20-60, Pheretima 20-40, Caulis Spatholobi 20-60, Scorpio 20-40, Sanguis Draxonis 10-30, Stigma Croci 10-30, eupolyphage sece steleophaga 10-30, catechu 10-30, drynaria baronii 20-60, Cordyceps 20-60, Fructus Lycii 20-60, Colla Plastri Testudinis 20-60, Semen Juglandis 30-70, Olibanum 20-40, Myrrha 20-40, Massa Medicata Fermentata 10-30, Fructus Crataegi 10-30, Fructus Hordei Germinatus 10-30.
2, the medicine of treatment hyperosteogeny according to claim 1 is characterized in that the weight portion of each component is: Radix Ginseng 40, Rhizoma Atractylodis Macrocephalae 30, Poria 20, Radix Glycyrrhizae 20, Radix Rehmanniae Preparata 50, Radix Angelicae Sinensis 40, Rhizoma Chuanxiong 30, Radix Paeoniae Rubra 20, Radix Astragali 50, Ramulus Cinnamomi 20, Radix Platycodonis 30, Radix Achyranthis Bidentatae 20, Cornu Cervi Pantotrichum 30, Placenta Hominis 40, Hippocampus 40, the Cortex Eucommiae 30, hair Canis familiaris L. 30, Radix Dipsaci 30, Herba Epimedii 30, Radix Salviae Miltiorrhizae 40, Pheretima 30, Caulis Spatholobi 40, Scorpio 30, Sanguis Draxonis 20, Stigma Croci 20, eupolyphage sece steleophaga 20, catechu 20, drynaria baronii 40, Cordyceps 40, Fructus Lycii 40, Colla Plastri Testudinis 40, Semen Juglandis 50, Olibanum 30, Myrrha 30, Massa Medicata Fermentata 20, Fructus Crataegi 20, Fructus Hordei Germinatus 20.
3, the medicine of treatment hyperosteogeny according to claim 1, described medicament are powder, tablet, capsule, granule, oral liquid.
4, a kind of preparation method for the treatment of the hyperosteogeny medicine, step is as follows: the weighting profit requires the described raw material of one of 1-2, grinds respectively, sieves, and with above-mentioned sieving mix homogeneously, makes medicament more according to a conventional method.
5, according to the preparation method of the treatment hyperosteogeny medicine of claim 4, described sieving is the 10-400 mesh sieve.
CNB031562655A 2003-09-02 2003-09-02 Medicine for treating osteoproliferation Expired - Fee Related CN1238021C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB031562655A CN1238021C (en) 2003-09-02 2003-09-02 Medicine for treating osteoproliferation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB031562655A CN1238021C (en) 2003-09-02 2003-09-02 Medicine for treating osteoproliferation

Publications (2)

Publication Number Publication Date
CN1490044A CN1490044A (en) 2004-04-21
CN1238021C true CN1238021C (en) 2006-01-25

Family

ID=34156907

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB031562655A Expired - Fee Related CN1238021C (en) 2003-09-02 2003-09-02 Medicine for treating osteoproliferation

Country Status (1)

Country Link
CN (1) CN1238021C (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103191342B (en) * 2013-03-31 2015-04-29 孟召华 Method for preparing diaphyseal aclasis nursing substance
CN103330880A (en) * 2013-05-28 2013-10-02 吴艾潼 Traditional Chinese medicine for treating hyperosteogeny
CN103784889B (en) * 2014-02-27 2016-05-11 马玉凤 The topical agent for the treatment of osteoproliferation
CN105708921A (en) * 2016-03-10 2016-06-29 深圳市水圣堂生物工程股份有限公司 Bone-nourishing oral solution

Also Published As

Publication number Publication date
CN1490044A (en) 2004-04-21

Similar Documents

Publication Publication Date Title
CN103656238B (en) A kind of Chinese medicine composition for the treatment of rheumatic osteopathia
CN101513437B (en) Antifatigue Chinese pharmaceutical composition and preparation method thereof
CN101361923A (en) Traditional Chinese medicine for treating rheumatism
CN103156972B (en) Traditional Chinese medicine combination for treating fracture, hairline fracture and traumatic injury
CN1895556A (en) Preparation for treating rheumatosis
CN1966004A (en) Medicament for treating cerebrovascular and cardiovascular disease and apoplexy sequelae
CN1840128A (en) Medicine for treating cardiovascular disease
CN1171599C (en) Plaster for treating pain in neck, shoulder, waist and leg and its prepn process
CN1868535A (en) Medicine composition for treating rheumatic arthritis and rheumatoid arthritis, and its prepn. method
CN1284567C (en) Medicinal liquid for treating osteoporosis and its preparation method
CN1288748A (en) Medicine for treating cardiac and cerebral vascular diseases and its preparation
CN102274481A (en) Chinese medicinal preparation for treating rheumatoid arthritis
CN101095768B (en) Chinese traditional medicine capsule for treating primary hypertension for persons in middle and old age
CN1876156A (en) Chinese medicinal ointment for treating bones and tendons injury pain
CN103566278B (en) Cortex torricelliae tiliifoliae
CN1238021C (en) Medicine for treating osteoproliferation
CN1233404C (en) Medicinal composition for treating amyotrophy
CN1079029C (en) Medical capsule for treating bone rheumatism and preparing process
CN1059594C (en) Chinese medicine Gutongning and its preparation
CN1086586C (en) Medicine for treating cardiac and cerebral vascular diseases and its preparation
CN1663577A (en) Chinese medicinal composition for treating rheumatic and rheumatoid arthritis
CN101284087B (en) Medicinal composition for curing lumbar disease
CN102370837A (en) Kidney-invigorating and tendon-reinforcing capsule
CN102370838B (en) Kidney-invigorating and tendon-reinforcing double-phase capsule
CN1231237C (en) Medicine for treating hyperosteogeny

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20060125

Termination date: 20091009